120 related articles for article (PubMed ID: 16734927)
1. Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population.
Ma SL; Tang NL; Lam LC; Chiu HF
Int Psychogeriatr; 2006 Mar; 18(1):37-45. PubMed ID: 16734927
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study.
Fu BY; Ma SL; Tang NL; Tam CW; Lui VW; Chiu HF; Lam LC
Int J Geriatr Psychiatry; 2009 Sep; 24(9):921-6. PubMed ID: 19212968
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
[TBL] [Abstract][Full Text] [Related]
5. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
[TBL] [Abstract][Full Text] [Related]
6. CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.
Juhász A; Rimanóczy A; Boda K; Vincze G; Szlávik G; Zana M; Bjelik A; Pákáski M; Bódi N; Palotás A; Janka Z; Kálmán J
Neurochem Res; 2005 Aug; 30(8):943-8. PubMed ID: 16258842
[TBL] [Abstract][Full Text] [Related]
7. An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.
He XM; Zhang ZX; Zhang JW; Zhou YT; Wu CB; Tang MN; Hong Z
J Mol Neurosci; 2012 Jul; 47(3):514-8. PubMed ID: 22528464
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
9. CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.
Li L; Yin Z; Liu J; Li G; Wang Y; Yan J; Zhou H
J Neurol; 2013 Jul; 260(7):1701-8. PubMed ID: 23070465
[TBL] [Abstract][Full Text] [Related]
10. CYP46A1 intron-2T/C polymorphism and Alzheimer's disease: an updated meta-analysis of 16 studies including 3,960 cases and 3,828 controls.
Li M; Wang W; Li Y; Wang L; Shen X; Tang Z
Neurosci Lett; 2013 Aug; 549():18-23. PubMed ID: 23792195
[TBL] [Abstract][Full Text] [Related]
11. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
Borroni B; Archetti S; Agosti C; Akkawi N; Brambilla C; Caimi L; Caltagirone C; Di Luca M; Padovani A
Neurobiol Aging; 2004 Jul; 25(6):747-51. PubMed ID: 15165699
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of cholesterol hydroxylases in Alzheimer's disease.
Brown J; Theisler C; Silberman S; Magnuson D; Gottardi-Littell N; Lee JM; Yager D; Crowley J; Sambamurti K; Rahman MM; Reiss AB; Eckman CB; Wolozin B
J Biol Chem; 2004 Aug; 279(33):34674-81. PubMed ID: 15148325
[TBL] [Abstract][Full Text] [Related]
13. CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease.
Li L; Zeng F; Liu YH; Li HY; Dong SY; Peng ZY; Wang YJ; Zhou HD
Mol Neurobiol; 2018 Oct; 55(10):8179-8187. PubMed ID: 29516283
[TBL] [Abstract][Full Text] [Related]
14. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.
Fourgeux C; Martine L; Björkhem I; Diczfalusy U; Joffre C; Acar N; Creuzot-Garcher C; Bron A; Bretillon L
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5712-7. PubMed ID: 19553612
[TBL] [Abstract][Full Text] [Related]
15. A study on the association of the chromosome 12p13 locus with sporadic late-onset Alzheimer's disease in Chinese.
Li Y; Chu LW; Li Z; Yik PY; Song YQ
Dement Geriatr Cogn Disord; 2009; 27(6):508-12. PubMed ID: 19451718
[TBL] [Abstract][Full Text] [Related]
16. Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients.
Li Y; Chu LW; Chen YQ; Cheung BM; Leung RY; Yik PY; Ng KM; Mak W; Jin DY; St George-Hyslop P; Song YQ
Dement Geriatr Cogn Disord; 2006; 22(5-6):399-404. PubMed ID: 16960449
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of CYP46 and risk for Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Dement Geriatr Cogn Disord; 2004; 18(3-4):257-60. PubMed ID: 15286456
[TBL] [Abstract][Full Text] [Related]
18. CYP46A1 functional promoter haplotypes decipher genetic susceptibility to Alzheimer's disease.
Li Y; Chu LW; Wang B; Yik PY; Huriletemuer ; Jin DY; Ma X; Song YQ
J Alzheimers Dis; 2010; 21(4):1311-23. PubMed ID: 20693622
[TBL] [Abstract][Full Text] [Related]
19. CYP46: a risk factor for Alzheimer's disease or a coincidence?
Golanska E; Hulas-Bigoszewska K; Wojcik I; Rieske P; Styczynska M; Peplonska B; Pfeffer A; Luczywek E; Wasiak B; Gabryelewicz T; Religa D; Chodakowska-Zebrowska M; Barcikowska M; Sobow T; Liberski PP
Neurosci Lett; 2005 Jul 22-29; 383(1-2):105-8. PubMed ID: 15936520
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease.
Papassotiropoulos A; Lambert JC; Wavrant-De Vrièze F; Wollmer MA; von der Kammer H; Streffer JR; Maddalena A; Huynh KD; Wolleb S; Lutjohann D; Schneider B; Thal DR; Grimaldi LM; Tsolaki M; Kapaki E; Ravid R; Konietzko U; Hegi T; Pasch T; Jung H; Braak H; Amouyel P; Rogaev EI; Hardy J; Hock C; Nitsch RM
Neurodegener Dis; 2005; 2(5):233-41. PubMed ID: 16909003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]